|
SLC10A7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.694600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.352200E-02 |
| Normal-vs-Stage2 |
8.534600E-01 |
| Normal-vs-Stage3 |
2.940800E-01 |
| Normal-vs-Stage4 |
9.654600E-01 |
| Stage1-vs-Stage2 |
4.359200E-01 |
| Stage1-vs-Stage3 |
9.505800E-01 |
| Stage1-vs-Stage4 |
4.651600E-01 |
| Stage2-vs-Stage3 |
5.236000E-01 |
| Stage2-vs-Stage4 |
8.867600E-01 |
| Stage3-vs-Stage4 |
5.607400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.925200E-01 |
| Normal-vs-AfricanAmerican |
2.028400E-01 |
| Normal-vs-Asian |
4.892600E-01 |
| Caucasian-vs-AfricanAmerican |
5.379600E-01 |
| Caucasian-vs-Asian |
7.913400E-01 |
| AfricanAmerican-vs-Asian |
7.588000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.717900E-02 |
| Normal-vs-Female |
6.452400E-01 |
| Male-vs-Female |
7.209800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.928600E-01 |
| Normal-vs-Extreme_Weight |
6.503800E-02 |
| Normal-vs-Obese |
4.319200E-01 |
| Normal-vs-Extreme_Obese |
2.996200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.267800E-01 |
| Normal_Weight-vs-Obese |
8.063600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.487800E-01 |
| Extreme_Weight-vs-Obese |
3.762800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.107200E-01 |
| Obese-vs-Extreme_Obese |
4.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.518400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.425800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.087800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.693170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.208200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.944600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.631200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.550820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.613600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.394800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.486200E-01 |
| Normal-VS-Type2 PRCC |
7.394200E-02 |
| Normal-VS-KIRP CIMP |
5.934000E-01 |
| Normal-VS-Unclassified PRCC |
2.740000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.159200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.925400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.209900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.305200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.977900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.130600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.080090E-02 |
| Normal-vs-N1 |
7.888000E-01 |
| Normal-vs-N2 |
7.453000E-01 |
| N0-vs-N1 |
3.664400E-01 |
| N0-vs-N2 |
4.446000E-01 |
| N1-vs-N2 |
6.691200E-01 |
|
|
